98 related articles for article (PubMed ID: 12052634)
1. AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains.
Jones RN; Anderegg TR; Deshpande LM
Diagn Microbiol Infect Dis; 2002 May; 43(1):87-90. PubMed ID: 12052634
[TBL] [Abstract][Full Text] [Related]
2. Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
Peric M; Lin G; Clark CL; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):95-100. PubMed ID: 12096012
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
Anderegg TR; Biedenbach DJ; Jones RN
J Antimicrob Chemother; 2002 Jun; 49(6):1019-21. PubMed ID: 12039896
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
Anderegg TR; Biedenbach DJ; Jones RN
Antimicrob Agents Chemother; 2002 Aug; 46(8):2662-4. PubMed ID: 12121951
[TBL] [Abstract][Full Text] [Related]
5. Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinone.
Anderegg TR; Jones RN
Int J Antimicrob Agents; 2004 Jan; 23(1):6-10. PubMed ID: 14732307
[TBL] [Abstract][Full Text] [Related]
6. Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.
Shanson DC; Tadayon M
J Hosp Infect; 1986 Mar; 7 Suppl A():65-72. PubMed ID: 2871099
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
8. In vitro bactericidal activity of daptomycin against staphylococci.
Fuchs PC; Barry AL; Brown SD
J Antimicrob Chemother; 2002 Mar; 49(3):467-70. PubMed ID: 11864946
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
Johnson AP; Warner M; Livermore DM
J Antimicrob Chemother; 2002 Jul; 50(1):89-93. PubMed ID: 12096011
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci.
Fluit AC; Schmitz FJ; Verhoef J; Milatovic D
J Antimicrob Chemother; 2002 Aug; 50(2):271-6. PubMed ID: 12161411
[TBL] [Abstract][Full Text] [Related]
11. AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro.
Wookey A; Turner PJ; Greenhalgh JM; Eastwood M; Clarke J; Sefton C
Clin Microbiol Infect; 2004 Mar; 10(3):247-54. PubMed ID: 15008947
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci.
Deshpande LM; Jones RN
Clin Microbiol Infect; 2003 Nov; 9(11):1120-4. PubMed ID: 14616730
[TBL] [Abstract][Full Text] [Related]
13. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
14. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
LaPlante KL; Rybak MJ
Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species.
Jones RN; Biedenbach DJ; Anderegg TR
Diagn Microbiol Infect Dis; 2002 Feb; 42(2):119-22. PubMed ID: 11858907
[TBL] [Abstract][Full Text] [Related]
16. Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.
Mutnick AH; Biedenbach DJ; Turnidge JD; Jones RN
Diagn Microbiol Infect Dis; 2002 May; 43(1):65-73. PubMed ID: 12052631
[TBL] [Abstract][Full Text] [Related]
17. In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.
Lam K; Bayer AS
Antimicrob Agents Chemother; 1984 Aug; 26(2):260-2. PubMed ID: 6091537
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
Van der Auwera P; Van Laethem Y; Klastersky J
J Antimicrob Chemother; 1987 Aug; 20(2):239-49. PubMed ID: 3478329
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Foleno BD; Abbanat D; Goldschmidt RM; Flamm RK; Paget SD; Webb GC; Wira E; Macielag MJ; Bush K
Antimicrob Agents Chemother; 2007 Jan; 51(1):361-5. PubMed ID: 17101672
[TBL] [Abstract][Full Text] [Related]
20. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
Ednie LM; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2002 Jul; 50(1):101-5. PubMed ID: 12096013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
